Global polymeric biomaterials market size is expected to reach US$ 121.52 Bn by 2030, from US$ 48.85 Bn in 2023, exhibiting a compound annual growth rate (CAGR) of 13.9% during the forecast period.
Polymeric biomaterials are polymers that are used as substitutes to replace or treat tissues or organs in the human body. They can be broadly categorized into biodegradable and non-biodegradable polymers. Biodegradable polymers such as polylactic acid (PLA), polyglycolic acid (PGA) and their copolymers are used for applications requiring temporary mechanical support or drug delivery systems. They have the advantage of degrading naturally in the body over time as the tissues heal and regenerate. Non-biodegradable polymers include silicone polymers and poly(methyl methacrylate) (PMMA). They are used for applications requiring long-term structural support and prosthetics. However, their non-degradable nature means that any remnants left in the body may cause chronic inflammation.
Within these categories are also natural and synthetic polymers. Natural polymers including collagen, gelatin, and fibrin are generally biodegradable and cause minimal immune response but have limited mechanical properties and reproducibility. Synthetic polymers on the other hand can be tailor-made to possess exact structural properties required but may provoke stronger immune responses. The selection depends on the desired application and its requirements in terms of mechanical integrity, biodegradability, and biocompatibility. Polymeric biomaterials have revolutionized modern medicine and enabled innovation ranging from bioresorbable sutures to tissue engineered organs.
Global Polymeric Biomaterials Market- Regional Insights
- North America is expected to be the largest market for polymeric biomaterials during the forecast period, accounting for over 7% of the market share in 2023. The presence of leading medical device manufacturers and biotechnology companies in the U.S. and Canada has created a huge demand for polymeric biomaterials in this region. The advanced healthcare infrastructure and higher healthcare expenditure per capita has enabled greater adoption of biomaterials-based medical products and therapies. Strong governmental support for biomedical research and the rapid translation of new technologies from the research labs into commercial products provides North American companies an edge over their global competitors.
- Asia Pacific market is expected to be the second-largest market for polymeric biomaterials market, accounting for over 25.2% of the market share in 2023. The Asia Pacific region has emerged as the fastest-growing market for polymeric biomaterials. Countries like China, Japan, India and South Korea are witnessing substantial economic growth which is improving access to healthcare. Growing medical requirements of the expanding middle class, along with rising aging populations, is driving significant investments into developing local biomaterials Existing industrial strengths in polymer manufacturing and processing also provide local supply networks for biomaterials producers. Lower manufacturing costs and a large talent pool of scientific professionals are enabling Asia Pacific (APAC)-based companies to produce high-quality biomaterials at competitive prices. This is attracting many multinational players to set up regional manufacturing hubs and research and development (R&D) centers in the Asia Pacific region.
- Europe market is expected to be the fastest-growing market for polymeric biomaterials market, with a share of 19.0% during the forecast period. The growth of the market in Europe is due to the increasing prevalence of coronary artery disease in the region.
Figure 1. Global Polymeric Biomaterials Market Share (%), By Region, 2023
To learn more about this report, request a free sample copy
Analyst View: The polymeric biomaterials market shows promising growth prospects. Increasing prevalence of chronic diseases such as cardiovascular disorders, cancer, and neurodegenerative diseases will drive the demand for advanced medical devices and equipment. Polymeric biomaterials are increasingly being used in implantable devices, surgical equipment, drug delivery systems, and tissue engineering due to their biocompatibility and biodegradability.
However, high R&D costs that are associated with developing new grades of biomaterials and obtaining regulatory approvals remains a key challenge to wider adoption. Stringent medical regulations also impact product development timelines and market entry for new players. The lack of reimbursements and high cost of treatments in developing regions restrict the market.
Nevertheless, the market witness opportunities from the growing geriatric population worldwide that are more susceptible to chronic diseases and disabilities. Advances in 3D printing and tissue engineering offer opportunities to custom design implants and prosthetics. Asian countries are emerging as lucrative markets. Especially countries like China, India and Japan due to growing healthcare investments, rising medical tourism, and increasing focus on native research capabilities in biomaterials and regenerative medicine. The North American region dominates due to established R&D facilities and supportive regulatory environment. But Asian markets are expected to surpass other regions in terms of market value over the long term.
Global Polymeric Biomaterials Market- Drivers
- Increasing orthopedic and dental applications: Orthopedic and dental applications are prominent drivers for the growth of the global polymeric biomaterials market. Polymers are increasingly being used in orthopedic implants, joint replacements, and other medical devices that go inside the human body. Their biocompatibility and ability to replicate the properties of bone and teeth tissues have made them the material of choice for applications that involve integration with living tissues. Many commonly used polymers like polyetheretherketone (PEEK), polycaprolactone (PCL) and polylactic-co-glycolic acid (PLGA) exhibit characteristics like strength, durability and flexibility that mimic natural tissues. They help in faster healing of fractures as implants made from these materials allow for bone ingrowth. This promotes integration of the implant with the surrounding tissue, thereby leading to long term stability and minimal rejection by the body. Polymeric biomaterials also alleviate the need for repeated surgeries to replace failing metallic implants over time. On the dental front, polymers are revolutionizing applications like dental fillings, crowns, bridges and aligners through 3D printing technologies. Resins and composites formed by polymerization processes enable custom modeling of dental structures. For example, clear aligners made of advanced polymers can straighten teeth without inflicting the discomfort of metal wires as in traditional braces. They are removing barriers to aesthetic orthodontic treatment. According to the American Association of Orthodontists, the number of cases using clear aligners grew by 50% between 2015-2019.
- Rising awareness about benefits of biomaterials: Rising awareness about the benefits of biomaterials is a key driver for the growth of the global polymeric biomaterials market. Biomaterials are increasingly being used in various medical applications due to their biocompatibility and ability to mimic natural body tissues. Polymeric biomaterials, in particular, have gained popularity due to their flexibility in material design, manufacturing process ability, and structural properties. Polymers can be easily synthesized and modified chemically to achieve desired properties matching natural tissues. This allows them to be tailored for specific applications. For example, biodegradable polymeric biomaterials have been formulated to degrade gradually and allow new tissue growth as the implant dissolves. Others are designed for permanent implantation such as polymeric hip and knee replacements. The customizability of polymers enables creating materials for minimally invasive procedures as well as organ regeneration applications. Rising disease burden along with an aging global population is increasing demand for medical devices and implants. At the same time, innovation in the field of tissue engineering and regenerative medicine is accelerating. Polymers are increasingly being researched and developed for advanced applications such as 3D bioprinting of tissues and organs. For instance, scientists are researching the use of polymeric biomaterials combined with living cells as "bio-inks" to print functional tissues such as ligaments, bones, and skin grafts. This is expected to transform treatment of chronic diseases and injuries in the future. According to the recent data by the United Nations, the percentage of global population aged over 65 will rise from 9% to 16% from 2020 to 2050. Elders are more prone to chronic diseases and injuries requiring polymeric medical implants and devices. According to the World Health Organization (WHO), chronic diseases accounted for 71% of global deaths in 2019. Cardiovascular diseases lead to over 18 Mn deaths annually worldwide. Such trends underscore the vast unmet need for advanced biomaterial based therapies.
Global Polymeric Biomaterials Market- Opportunities
- Emerging markets in Asia Pacific and Latin America: Emerging economies in the Asia Pacific and Latin American regions provide immense opportunities for growth in the global polymeric biomaterials market. These developing nations are witnessing rapid urbanization and economic development which has bolstered the growth of their healthcare sectors tremendously. According to the statistics published by the World Bank, in 2022, healthcare expenditure as a percentage of gross domestic product (GDP) has increased substantially in countries such as India, Indonesia, Brazil, and Mexico, indicating greater government focus and investments to strengthen healthcare infrastructure and facilitate improved access to advanced medical treatments for more people. With the continual expansion of medical services across urban and rural populations alike in these regions, the demand for advanced biomaterial-based technologies for applications such as surgical repair and replacement of tissues is projected to multiply. Bioresorbable polymeric biomaterials that assist in tissue regeneration are gaining widespread acceptance for use in various surgical specialties including orthopedics, dentistry, cardiology and wound care. Their ability to degrade naturally in the body post implantation, eliminating the need for subsequent surgical removal of permanent prostheses, makes them extremely suitable for healthcare delivery in developing nations. Some notable biomaterial-based products gaining ground include biodegradable polymeric scaffolds for bone and cartilage regeneration, absorbable sutures and staples for wound closure, and biodegradable stents prominently featuring in interventional cardiology procedures. For example, according to the World Health Statistics published by the World Health Organization (WHO) in 2022, India witnessed a massive 41% increase in the number of percutaneous coronary intervention (PCI) procedures between 2015 to 2020, thereby cementing its position as one of the highest PCI performing countries worldwide. Such rapidly evolving clinical landscapes prove conducive for the uptake of advanced biodegradable biomaterial technologies that is aimed at simplifying treatment paths. Considering factors such as the growing economic ability of populations to access private and public healthcare combined with governments prioritizing healthcare development, the polymeric biomaterials market is expected to harness significant gains across Asia Pacific and Latin American countries.
- Innovation of new biomaterial-based products: Innovation of new biomaterial-based products could provide a major opportunity in the global polymeric biomaterials market. Biomaterials are developed using polymers to be biocompatible and biofunctional for medical applications. Polymeric biomaterials have an edge as they can be molded easily into various medical devices and implants. The demand for biomaterials is expected to grow significantly in the near future due to rapid advancements in medical technology as well as rising healthcare needs worldwide. According to the recent estimates by World Health Organization, globally non-communicable diseases are projected to burden 70% of overall disease by 2030. This increasing disease prevalence will fuel the demand for advanced treatments like tissue engineering and regenerative medicines that utilize biomaterials. Various new polymers are under research that can replicate properties of human tissues much better than existing biomaterials. Researchers are also working on designing smart biomaterials that can dynamically interface with biological tissues for improved therapeutic outcomes. 3D printing technology in particular holds promise for customized prosthetics, implants and tissue scaffolds by using such candidate biomaterials. The market players are continuously investing in R&D to develop biomaterial-based products for various applications like orthopedics, cardiology, dentistry, neurological disorders etc. For instance, a new bio-compatible and biodegradable polymeric biomaterial was under clinical trial in 2020-21 for minimally invasive spinal disc replacement according to study published in Biomaterials Journal. Such innovations not only provide new treatment solutions but also have capability to disrupt existing medical devices market in long run. As disorders affecting musculoskeletal system and cardiac health become more prevalent worldwide, demand for next-gen biomaterial-based implants and assistive devices will keep rising in future.
Global Polymeric Biomaterials Market Report Coverage
| Report Coverage |
Details |
|---|
| Base Year: |
2022 |
Market Size in 2023: |
US$ 48.85 Bn |
|---|
| Historical Data for: |
2018 to 2021 |
Forecast Period: |
2023 - 2030 |
|---|
| Forecast Period 2023 to 2030 CAGR: |
13.9% |
2030 Value Projection: |
US$ 121.52 Bn |
|---|
| Geographies covered: |
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
|
| Segments covered: |
- By Product: Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethanes, Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE), Polyaryletheretherketone (PEEK), Polydioxanone (PDO) and Others
- By Application: Cardiovascular (Bioresorbable Stents, Vascular Grafts, Sensors, Guidewires, Implantable Cardiac Defibrillators, Pacemakers, and Others), Dental (Tissue Regeneration Materials, Dental Implants, Bone Grafts & Substitutes, Dental Membranes, Dental Sutures and Others), Orthopedic (Joint Replacement Polymeric Biomaterials, Tissue Fixation Products (Suture Anchors and Others), Orthobiologics, Viscosupplementation, Spine Biomaterials and Others), Plastic Surgery (Facial Wrinkle Treatment, Soft Tissue Fillers, Craniofacial Surgery (Sutures and Others), Bioengineered Skins, Peripheral Nerve Repair, Acellular Dermal Matrices and Others), Neurology (Neural Stem Cell Encapsulation, Shunting Systems, Hydrogel Scaffold For CNS Repair, Cortical Neural Prosthetics and Others) and Others)
|
| Companies covered: |
Stryker, BASF SE, Evonik Industries AG, DSM, Bezwada Biomedical, LLC, Corbion, Victrex plc (Invibio Ltd.), International Polymer Engineering, Covalon Technologies Ltd., Medtronic, Abbott, Elixir Medical, REVA Medical, LLC, Meril Life Sciences Pvt. Ltd., and MicroPort Scientific Corporation.
|
| Growth Drivers: |
- Increasing orthopedic and dental applications
- Growing demand for wound healing applications
|
| Restraints & Challenges: |
- High cost of biomaterial-based products
- Stringent regulatory environment
|
Global Polymeric Biomaterials Market- Trends
- Increased adoption of biodegradable polymers: Increased adoption of biodegradable polymers is having a significant impact on the global polymeric biomaterials market. More companies and consumers are looking for sustainable and eco-friendly options which have boosted the demand for biodegradable polymers in various applications. Biodegradable polymers are derived from renewable plant-based resources thus making them a more viable alternative to conventional plastics which are made from fossil fuels and often end up as plastic waste in the environment. Some of the key biodegradable polymers in demand include polylactic acid (PLA), polyhydroxyalkanoates (PHA), polybutylene succinate (PBS) and biopolyesters. These polymers can degrade in compost or ambient conditions within a span of months without leaving any toxic residues. Products made from biodegradable polymers include bioplastics, medical implants, tissue engineering scaffolds, drug delivery devices and others. The medical industry has especially warmed up to the usage of biodegradable polymeric biomaterials for resorbable surgical devices and implants. For example, PLA is commonly used to make dissolvable stitches and bone fixation devices that naturally degrade and dissolve in the body after conducting their functions.
- Customizability of biomaterial properties: The ability to custom design biomaterials with tailored properties at a molecular level has opened up new possibilities and is driving significant innovation in the global polymeric biomaterials market. With advanced material engineering and synthesis techniques, researchers and manufacturers have unprecedented control over biomaterial characteristics such as biodegradability, mechanical integrity, surface properties, and interaction with surrounding physiological environments. This allows them to precisely match material performance with a wide range of clinical application requirements. Polymeric biomaterials can be designed by using complex algorithms that optimize macromolecular structures for specific use cases. For example, a material intended for bone regeneration may need to gradually degrade and transfer stress load in growing tissue, while one used as a scaffold for neuronal growth should have attributes that closely mimic the natural extracellular matrix and promote cell adhesion. The trend towards customizability is empowering researchers to develop new biomaterial formulations with human tissues and organs in mind. Major companies are investing heavily in R&D to come up with cutting-edge polymers that can be customized for diverse medical specialties such as orthopedics, neurology, vascular grafts, and soft tissue repair.
Global Polymeric Biomaterials Market - Restraints
- High cost of biomaterial-based products: The high cost of biomaterial-based products is significantly restraining the growth of the global polymeric biomaterials market. Biomaterial-based medical devices and implants are generally much more expensive than conventional treatment options since they require expensive raw materials and an intricate manufacturing process. For example, according to the data by the World Bank, the average cost of a hip replacement surgery utilizing a biomaterial implant in the U.S. is over US$ 40,000. In comparison, traditional joint replacement procedures without polymers typically cost under US$ 15,000. Similarly, in Europe, the average costs of heart valves made from biomaterials are 3-4 times higher than tissue/metal valves according to Eurostat. This high price tag that is associated with biomaterial-based offerings poses affordability challenges, especially in developing regions with lower per capita incomes and limited healthcare budgets. Many patients in these areas are unable to afford such expensive treatments and procedures upfront due to inadequate insurance coverage or high deductibles. As a result, a significant proportion of the global population has very limited or no access to the benefits of advanced polymeric biomaterials. Even in developed markets, the increasing healthcare expenditures associated with these high-priced products place considerable financial burdens on patients as well as public and private insurance providers. This unfavorably impacts the growth and widespread adoption of biomaterial technologies. To make biomaterial-based medical solutions more economically viable and expand their reach, companies are investing heavily in research and development activities aimed at reducing manufacturing costs through process optimization and automation. For instance, in 2020, according to a report by the World Health Organization, researchers are exploring new techniques like3D-printing of biomaterials that could lower production costs by 40-60% as compared to traditional techniques. Continued innovations to drive down costs through such technological advancements will be vital for the polymeric biomaterials industry to overcome affordability barriers over the long-run and unlock its true market potential on a global scale.
Counterbalance: The key market players should implement proper and adequate insurance coverages for the patients who are unable to afford the biomaterial based treatments due to high costs.
- Stringent regulatory environment: The stringent regulatory environment across the globe is presenting significant challenges for the growth of the global polymeric biomaterials market. Complying with regulations related to biocompatibility, toxicity, and safety has become increasingly complex. Polymeric biomaterials are extensively utilized in medical applications ranging from artificial implants and devices to tissue engineering constructs. However, obtaining regulatory approval for new polymeric biomaterials and related medical products has become a lengthy and expensive process. Regulatory agencies across regions like North America, Europe, and Asia Pacific have made revisions to existing norms and introduced new guidelines to ensure the materials and technologies that are used inside the human body do not cause any adverse health effects. For example, in Europe the Medical Device Regulation 2017/745 replaced the earlier medical device directive and imposed stricter pre-market scrutiny and post-market surveillance protocols for manufacturers. Complying with the new regulation involved significant investments into upgrading quality management systems, conducting detailed clinical trials, and providing richer technical documentation for submissions. This increased the costs and timelines for bringing new polymeric biomaterial-based products to the European market. Similarly, the U.S. Food and Drug Administration (FDA) have taken up steps to strengthen oversight of Class III medical devices which are generally implanted inside the body for long term use. According to a report by the U.S. FDA, in 2020, the median time taken for review and approval for such high-risk devices was increased to 208 days as compared to 180 days. Such review times can be detrimental for technologies depending on rapid uptake in the market. The policies by regulators aim to ensure patient safety but end up delaying market access for companies. This regulatory hurdle is proving to be a restraint that is slowing the adoption of advanced polymeric biomaterials and curbing the growth momentum of this market globally.
Figure 2. Global Polymeric Biomaterials Market Share (%), By Product, 2023
To learn more about this report, request a free sample copy
Global Polymeric Biomaterials Market- Recent Developments
Product and Technology Launch
- On March 8, 2023, Invibio Ltd., a medical device company made waves with the introduction of its PEEK-OPTIMA AM filament. This product is specifically designed for the additive manufacturing sector within the medical device industry, offering optimized performance and precision.
- On January 2023, MicroPort Scientific Corporation, a medical device company celebrated a significant milestone with the acquisition of marketing authorization for its firehawk liberty rapamycin target eluting coronary stent system within the Russian market.
Business Development Activities by the Market Players
- On February 27, 2023, Victrex plc. the parent company of Invibio Ltd., publicized the expansion of Invibio's R&D and production capabilities that is dedicated to medical advancements. This expansion was marked by the inauguration of their new product development facility located in Leeds, U.K.
Top Companies in Global Polymeric Biomaterials Market
- Stryker
- BASF SE
- Evonik Industries AG
- DSM
- Bezwada Biomedical, LLC
- Corbion
- Victrex plc. (Invibio Ltd.)
- International Polymer Engineering
- Covalon Technologies Ltd.
- Medtronic
- Abbott
- Elixir Medical
- REVA Medical, LLC
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
Definition: Polymeric biomaterials are materials engineered from synthetic or natural polymers that are utilized in various medical applications. These materials possess a diverse range of physical and chemical properties, thereby making them suitable for use in tissue engineering, drug delivery systems, medical devices, and implants within the human body due to their biocompatibility, tunable degradation rates, and structural versatility.
U.S.: 
U.K. : 
India :